1-6 of 6
Jean-Philippe Spano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract RF3-03: Nivolumab + Ipilimumab (NIVO+IPI) compared to capecitabine for triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy – Final results of BreastImmune-03, a multicenter randomized open-label phase II trial

Free
Olivier Trédan, Delphine Loirat, Sylvie Chabaud, Thierry Petit, Frédéric Viret, Christelle Levy, Philippe Toussaint, Aurélien Robert, Julien Grenier, Laura Mansi, Jean-Philippe Spano, Anne Patsouris, Olfa Derbel, Christelle Jouannaud, Jean Marc Ferrero, Jean Sébastien Frenel, Yann Molin, Louis Doublet, Pierre-Etienne Heudel, Mathilde Bernardin, Delphine Tatu, Gwenaële Garin, David Pérol, Jean-Yves Pierga, Thomas Bachelot
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): RF3-03.
https://doi.org/10.1158/1557-3265.SABCS24-RF3-03
Published: 13 June 2025
View article titled, Abstract RF3-03: Nivolumab + Ipilimumab (NIVO+IPI) compared to capecitabine for triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy – Final results of BreastImmune-03, a multicenter randomized open-label phase II trial
Journal Articles

An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas

Available to Purchase
Xiaofan Lu, Yann Vano, Alexandra Helleux, Xiaoping Su, Véronique Lindner, Guillaume Davidson, Roger Mouawad, Jean-Philippe Spano, Morgan Rouprêt, Reza Elaidi, Eva Compérat, Virginie Verkarre, Chengming Sun, Christine Chevreau, Mostefa Bennamoun, Hervé Lang, Thibault Tricard, Wenxuan Cheng, Li Xu, Irwin Davidson, Fangrong Yan, Wolf Herman Fridman, Catherine Sautes-Fridman, Stéphane Oudard, Gabriel G. Malouf
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (7): 1279–1291.
https://doi.org/10.1158/1078-0432.CCR-22-2133
Published: 03 April 2023
View article titled, An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
Open the PDF for An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas in another window
Includes: Supplementary data
Journal Articles

High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)

Free
Saranya Chumsri, Jeff Sperinde, Heshan Liu, Joseph Gligorov, Jean-Philippe Spano, Martine Antoine, Alvaro Moreno Aspitia, Winston Tan, John Winslow, Christos J. Petropoulos, Ahmed Chenna, Michael Bates, Jodi Marie Weidler, Weidong Huang, Amylou Dueck, Edith A. Perez
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (13): 3053–3058.
https://doi.org/10.1158/1078-0432.CCR-17-1864
Published: 01 July 2018
View article titled, High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Open the PDF for High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance) in another window
Journal Articles

DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas

Free
Gabriel G. Malouf, Xiaoping Su, Jianping Zhang, Chad J. Creighton, Thai H. Ho, Yue Lu, Noël J.-M. Raynal, Jose A. Karam, Pheroze Tamboli, Frederick Allanick, Roger Mouawad, Jean-Philippe Spano, David Khayat, Christopher G. Wood, Jaroslav Jelinek, Nizar M. Tannir
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (24): 6236–6246.
https://doi.org/10.1158/1078-0432.CCR-15-1217
Published: 15 December 2016
View article titled, DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
Open the PDF for DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas in another window
Includes: Supplementary data
Journal Articles

Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS–RAF Mutations

Free
Lisa Zimmer, Fabrice Barlesi, Maria Martinez-Garcia, Veronique Dieras, Jan H.M. Schellens, Jean-Philippe Spano, Mark R. Middleton, Emiliano Calvo, Luiz Paz-Ares, James Larkin, Simon Pacey, Miro Venturi, Françoise Kraeber-Bodéré, Jean J.L. Tessier, Wilfried Ernst Erich Eberhardt, Michel Paques, Ernesto Guarin, Valerie Meresse, Jean-Charles Soria
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4251–4261.
https://doi.org/10.1158/1078-0432.CCR-14-0341
Published: 13 August 2014
View article titled, Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS–RAF Mutations
Open the PDF for Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS–RAF Mutations in another window
Includes: Supplementary data
Journal Articles

Nuclear Localization of Apoptosis Protease Activating Factor-1 Predicts Survival after Tumor Resection in Early-Stage Non–Small Cell Lung Cancer

Free
Benjamin Besse, Céline Candé, Jean-Philippe Spano, Antoine Martin, David Khayat, Thierry Le Chevalier, Thomas Tursz, Laure Sabatier, Jean-Charles Soria, Guido Kroemer
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (17): 5665–5669.
https://doi.org/10.1158/1078-0432.CCR-04-0415
Published: 08 September 2004
View article titled, Nuclear Localization of Apoptosis Protease Activating Factor-1 Predicts Survival after Tumor Resection in Early-Stage Non–Small Cell Lung Cancer
Open the PDF for Nuclear Localization of Apoptosis Protease Activating Factor-1 Predicts Survival after Tumor Resection in Early-Stage Non–Small Cell Lung Cancer in another window